Duagen

Quick links to important sections

Duagen

Selected form

Method of action: Antiandrogenic, Urologicals

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Duagen

Property Description
Active Ingredient Dutasteride
Form Soft Gelatin Capsule
Pharmacological Class 5-Alpha-Reductase Inhibitor (Dual Inhibitor)
General Purpose Reduction of Dihydrotestosterone (DHT) levels
Origin Synthetic 4-azasteroid

What is Duagen and What is its Pharmacological Class?

Duagen is a prescription medication whose active ingredient is Dutasteride, a potent, synthetic 4-azasteroid compound. It is specifically classified as a 5-Alpha-Reductase Inhibitor (5ARI). It functions through hormonal modulation.

The drug is clinically recognized as a dual inhibitor because it selectively and potently blocks both the Type 1 and Type 2 isoforms of the 5alpha-reductase enzyme, which is a key characteristic differentiating it from related single-inhibitor agents. As a single-ingredient pharmaceutical preparation, Duagen’s identity is defined entirely by the action and chemical structure of Dutasteride.

Composition and Pharmaceutical Form of Duagen

Duagen is formulated as an oblong, opaque, dull yellow soft gelatin capsule intended for oral administration. The soft gelatin capsule is the exclusive and definitive pharmaceutical form for this medication.

The active substance, Dutasteride, is dissolved in an oily solution inside the gelatin shell. This specific composition is utilized to ensure the stability of the compound and to promote optimal absorption into the bloodstream. The oily vehicle is a differentiating feature of the capsule design to achieve consistent drug bioavailability.

General Purpose of Duagen's Hormonal Action

The general therapeutic purpose of Duagen is directly linked to its primary action: significantly reducing the body's levels of the hormone Dihydrotestosterone (DHT). It achieves this by blocking the key enzyme responsible for converting Testosterone into DHT.

Since DHT is recognized as a principal growth factor that stimulates the proliferation of specific hormone-sensitive tissues in adult males, the fundamental benefit of Duagen is to modulate this hormonal drive. By controlling the concentration of DHT, the medication serves to oppose the growth-promoting stimulus of the hormone, providing the essential basis for its general therapeutic utility, typically in conditions related to tissue growth.

Regulatory References

  1. NIH-DailyMed

What side effects are possible with Duagen ?

Possible Side Effects and Safety Information

The official safety profile for Duagen (Dutasteride) is defined by its anti-androgenic effects, with adverse reactions formally categorized by frequency and the body system affected, consistent with regulatory standards.

Adverse Reactions Classified by Frequency

Side effects are most frequently observed within the Reproductive System and Breast Disorders class. Common reactions, which are reported in a higher percentage of patients, include impotence (inability to maintain an erection), decreased libido (sex drive), ejaculation disorders, and breast disorders such as tenderness and enlargement (gynecomastia).

Uncommon reactions, which are less frequently observed, include hypersensitivity events like rash and urticaria, as well as depressed mood, testicular pain, and testicular swelling. Severe hypersensitivity reactions like angioedema are documented as rare.

Regulatory Safety Constraints

Official regulatory documents contain important safety restrictions. Duagen is contraindicated for use in women and children. Women who are or may be pregnant must avoid contact with damaged capsules due to the potential for absorption and resulting risk to a male fetus (teratogenicity).

Regarding the timing of effects, sexual adverse reactions are noted in labeling to be more common at the start of treatment and generally diminish with long-term exposure. Regulatory documentation also includes reports of male breast cancer and persistent sexual dysfunction from post-marketing surveillance. Use in patients with severe hepatic impairment has not been established.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation reports that no specific symptoms or clinical signs of acute Duagen (Dutasteride) overdose are formally documented, even following administration of doses significantly higher than recommended. The management of any suspected overexposure is based on general principles of supportive medical care.

Category Official Regulatory Statement
Documented Manifestations No specific symptoms or clinical signs of acute overdose are formally documented in official regulatory labeling.
Immediate Action Contact a Poison Control Center is required for suspected overdosage.
Urgent Help Required Immediate contact with emergency services is mandated if the person has collapsed, has a seizure, has trouble breathing, or cannot be awakened.
Antidote Information No specific antidote is known for Dutasteride overdose.
Supportive Management Management must consist of symptomatic and supportive treatment.
Monitoring Requirement Due to the long terminal half-life (approximately five weeks), prolonged monitoring may be necessary following overdose.

Connection to the Overall Overdose Profile

The regulatory documents define the overdose profile by the lack of specific acute toxicity and the necessity for prolonged clinical observation. The conditions for seeking immediate medical help are explicitly stated by governmental authorities and are tied to general, life-threatening clinical signs, reinforcing that urgent contact with emergency services is mandated when these severe endpoints are present.

Therapeutic Uses of Duagen

Duagen is an approved medication used to manage symptoms associated with chronic inflammatory conditions. It is indicated for use in clinical scenarios where consistent symptomatic support is needed, such as in the management of pain and stiffness related to osteoarthritis and rheumatoid arthritis. The medication may also be prescribed to provide relief during acute episodes of soft tissue inflammation and certain types of persistent joint discomfort. The primary patient benefit is the ability to help reduce the severity of symptoms and contribute to improved functional capacity, which aids in maintaining daily activity levels. The goal of treatment is to support overall patient well-being and better symptom control.


Quick Fact: Relief for Pain and Stiffness


Regulatory References

  1. NIH MedlinePlus guidance on NSAID-class drugs

Eligibility and Restrictions for Use

Eligibility for Duagen (Dutasteride) is defined by official regulatory criteria, strictly limiting use to specific populations.

Category Regulatory Status
Allowed Population Adult Males (18 years and older), including geriatric patients.
Absolute Contraindications Women (of any age), Pediatric Patients (under 18), and patients with Severe Hepatic Impairment.

Non-Eligibility Rules

Duagen is officially contraindicated in all women due to the risk of fetal harm (teratogenicity) to a male fetus. For this reason, women who are pregnant or may become pregnant must not handle leaking or damaged capsules. The medicine is also contraindicated for any individual with a known hypersensitivity or allergic reaction to dutasteride, other 5-alpha reductase inhibitors, or the formulation's excipients (such as soy or peanut).

Restricted and Conditional Use

The regulatory label establishes that use is not suitable for children or adolescents, as safety and efficacy have not been established. While no dose adjustment is necessary for patients with renal impairment, caution should be used when administering Duagen to patients with mild to moderate hepatic impairment. Additionally, men taking Duagen are directed not to donate blood for at least 6 months following their last dose to prevent drug transmission to a female recipient.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Duagen (Dutasteride) exhibits specific pharmacokinetic interaction patterns primarily governed by its metabolic clearance. Regulatory documentation identifies that Dutasteride is extensively broken down by the CYP3A4 and CYP3A5 enzymes in the liver. This metabolic pathway is the basis for its most significant documented drug interactions.

Co-administration with potent CYP3A4 inhibitors is documented to cause a clinically significant increase in Dutasteride exposure (AUC and Cmax) due to reduced clearance. Potent inhibitors, such as Itraconazole and Ritonavir, can increase the total systemic exposure of Dutasteride by approximately 2.5-fold, a formal constraint noted in official labeling. Moderate CYP3A4 inhibitors, including Verapamil and Diltiazem, are also documented to raise plasma concentrations, though to a lesser degree.

Administration and Clearance Constraints

Constraint Area Regulatory Status
Drug-Food Interaction No effect on bioavailability; may be taken with or without food.
Timing Separation No mandatory time-separation rules are specified for co-administration.
Hepatic Impairment Use is formally contraindicated in patients with severe liver function impairment due to reduced clearance.

No clinically significant pharmacodynamic interactions are noted with common co-administered drug classes, such as alpha-blockers. The only formal restriction not tied to metabolic inhibition is the contraindication in individuals with severe hepatic impairment, related to the drug's dependence on liver clearance.

Mechanism of Action

Mechanisms of Action

The drug acts through two distinct, complementary biological pathways to influence lower urinary tract physiology.


Enzyme Inhibition for Structural Reduction

This mechanism involves the component dutasteride, an inhibitor that forms a stable, irreversible complex with the 5alpha-reductase enzyme. This enzyme normally converts testosterone into the potent androgen dihydrotestosterone (DHT). By blocking this conversion, the medication dramatically lowers DHT levels, which are the primary hormonal stimulus for prostate tissue growth. This gradually results in a long-term, structural decrease in the overall volume and mass of the prostate gland.


Receptor Antagonism for Functional Relaxation

This action is mediated by the component tamsulosin, which functions as a selective antagonist (blocker) of alpha1-adrenergic receptors on smooth muscle cells in the lower urinary tract. By preventing the sympathetic nervous system from signaling muscle contraction, this mechanism causes the smooth muscle in the bladder neck and prostate to rapidly relax. This provides an immediate physiological adjustment by reducing the dynamic resistance to urinary flow.

Dosage and Administration Information

Administration Guidelines for Duagen

Duagen (dutasteride) is for oral administration and is to be taken only by adult males. The medication is supplied as a soft gel capsule and must be used according to a specific daily dosing and preparation protocol.

Administration Scope Instructions for Use
Route & Dosing One 0.5 mg capsule taken orally once daily.
Preparation The capsule must be swallowed whole with a glass of water. Do not chew, crush, or open the capsule, as contact with the contents may cause irritation of the oropharyngeal mucosa.
Timing May be taken with or without food. Taking the dose at approximately the same time each day is recommended to maintain a consistent plasma level.
Missed Dose If a dose is missed, the patient should take the missed dose as soon as it is remembered on the same day. If the next day has already arrived, skip the missed dose and resume the regular dosing schedule. Do not take two doses at one time to make up for a missed dose.

No dose adjustment is necessary for elderly patients or patients with renal impairment. However, Duagen is strictly contraindicated for use in women and in the pediatric population. The administration is a long-term commitment, and patients should continue therapy as prescribed, even if symptomatic improvement is observed early in treatment.

Recent Clinical Evidence

Recent Clinical Evidence


Clinical Development Program

Research studies exploring the potential link to changes in clinical measures in men with Benign Prostatic Hyperplasia (BPH) centered on three pivotal Phase 3 randomized, controlled trials. The evidence gathered included data from these core trials, two Phase 2 dose-finding studies, and long-term extension trials, providing data for up to four years of observation.

Key Findings from Phase 3 Trials (BPH)

In the Phase 3 trials, the studies were designed to assess changes in key urological measurements over 12 months, compared to placebo.

Measurement Change from Baseline (Duagen) Change from Baseline (Placebo)
AUA Symptom Index (AUASI) -3.3 units -2.1 units
Prostate Volume -24.6% -3.4%
Maximum Urinary Flow Rate (Qmax) +1.6 cc/sec +0.7 cc/sec

Significant changes in prostate volume were measured as early as one to three months after the initiation of treatment, and these reductions were maintained over a 24-month period in the double-blind phase.

️ Safety and Tolerability Profile Review

Reported safety findings across the clinical trials were analyzed in thousands of patients. The trial design included a review period of at least 12 months, with some extension studies lasting up to four years. The most common adverse events reported were consistent with the drug's mechanism of action, including effects related to the reproductive system. Research was conducted that involved patients who had mild liver impairment to assess safety in this population.

Prostate-Specific Antigen (PSA) Measurement

Clinical data showed that Duagen is associated with a reduction in serum PSA levels by approximately 50% after six months of use. This reduction was observed across the range of baseline PSA values studied. Adjustments to PSA interpretation are generally needed for men taking this drug.

Frequently Asked Questions (FAQ)

Common questions about Duagen (FAQ)

Q: How quickly does Duagen typically start working?

A: Regulatory product information notes that the medicine has two different timelines for observed effects. The functional effect on urinary flow may be observed within a few weeks, while the structural reduction in prostate size associated with the dutasteride component may require six months or longer to achieve its noted effects.

Q: How is Duagen different from other medications for the same condition?

A: Duagen is officially described as a combination therapy, containing two distinct active ingredients: dutasteride and tamsulosin. These components offer two complementary mechanisms—one to reduce the physical size of the prostate gland and another to relax the muscle tissue. This combination of ingredients distinguishes it from single-component treatments for the same condition.

Q: Does taking Duagen require regular blood tests or monitoring?

A: Official regulatory documents indicate that routine blood testing to measure PSA (Prostate-Specific Antigen) levels is necessary for men taking this medication. The drug is known to reduce the amount of PSA in the blood, and healthcare providers must account for this effect when interpreting the test results for prostate cancer screening.

Q: What happens if a child accidentally takes Duagen?

A: Duagen is strictly contraindicated for use in children and must be kept out of their reach. Accidental ingestion by a child is considered a medical event, and emergency medical attention is typically required.

Q: Is Duagen available in different strengths or forms?

A: The medicine is typically formulated and available as a single combination capsule. This capsule contains a fixed strength of 0.5 mg of dutasteride and 0.4 mg of tamsulosin.

Q: What is the mechanism of action of Duagen in simple terms?

A: The medicine has a dual action. First, it reduces the overall size of the enlarged prostate gland over time by lowering the hormone DHT (dihydrotestosterone). Second, it rapidly relaxes the muscles around the bladder neck and prostate to improve urinary flow.

Q: What is the main reason doctors prescribe Duagen?

A: Official product labeling indicates that Duagen is prescribed for the treatment of symptomatic benign prostatic hyperplasia (BPH) in adult men. This condition is commonly known as an enlarged prostate.

Q: Does Duagen cause drowsiness or affect my ability to drive?

A: The alpha-blocker component of the drug may cause side effects such as dizziness, lightheadedness, or fainting, especially when standing up quickly. Official labeling contains a warning that caution should be exercised when driving or operating machinery due to the potential for these side effects.

Q: Is it common to feel worse before feeling better when starting Duagen?

A: Some side effects, such as dizziness and certain reproductive issues, may be reported more frequently at the beginning of therapy and often lessen over time. Regulatory guidelines emphasize the need for long-term therapy, and treatment should be continued as prescribed.

Q: Can Duagen affect blood pressure or heart rate?

A: Yes, the tamsulosin component can affect blood pressure. It may cause a drop in blood pressure, known as orthostatic hypotension, which may lead to feelings of dizziness or fainting, particularly upon changing position rapidly.

Q: Are there any specific lifestyle changes recommended while taking Duagen?

A: Regulatory safety information includes a constraint that men using this medicine should not donate blood for a minimum of 6 months following their last dose. This constraint is in place to prevent drug exposure to a female recipient who may be pregnant.

Q: What happens if I stop taking Duagen suddenly?

A: The drug is intended for long-term management of BPH. Since the medicine provides structural reduction of the prostate over time, discontinuing therapy may be associated with a potential for the return or worsening of urinary symptoms.

Q: Are there generic versions of Duagen available?

A: Yes, the active ingredients in Duagen, dutasteride and tamsulosin, are available from generic manufacturers.

Q: Does Duagen have any known interactions with alcohol?

A: The tamsulosin component can increase the risk of side effects like dizziness and fainting if taken concurrently with alcohol. Regulatory information indicates that limiting or avoiding alcohol consumption is generally suggested.

Q: Where can I find the official prescribing information for Duagen?

A: You can locate the official prescribing information on government-sponsored resources. For example, the FDA DailyMed database provides the official US labeling, and the European Medicines Agency (EMA) publishes the Summary of Product Characteristics (SmPC).

Q: Is Duagen used to treat any other conditions besides the main one?

A: The medication is only approved by regulatory bodies for the treatment of symptomatic benign prostatic hyperplasia (BPH). It is not indicated for the prevention of prostate cancer or for any other conditions.

Q: What is the risk of dependence or addiction with Duagen?

A: The medication is not classified as a controlled substance by the Drug Enforcement Administration. Therefore, it is not associated with an elevated risk of dependence or addiction.

Q: Does Duagen affect fertility?

A: Studies on the dutasteride component have observed changes in semen characteristics, including a decrease in semen volume, sperm count, and sperm motility. The clinical significance of these changes on a male patient’s long-term fertility has not been established in regulatory documentation.

Q: What should I avoid eating or drinking while on Duagen?

A: Regulatory information indicates that limiting or avoiding alcohol consumption is generally suggested. Otherwise, the medicine can be taken with or without food, but caution is advised with strong inhibitors of the CYP3A4 enzyme, which may be found in some foods or supplements.

Q: What should I mention to my doctor before starting Duagen?

A: The product label highlights the importance of discussing all current medications, any history of severe liver impairment, blood pressure issues, or known allergies to the drug’s components or other related 5-alpha reductase inhibitors prior to starting the medicine.

Q: What are the symptoms that Duagen is intended to relieve?

A: The medicine is intended to relieve the urinary symptoms associated with BPH. These commonly include the need for frequent urination, a weak urinary flow, and difficulty in starting urination.

Q: Can Duagen interact with birth control pills?

A: While the drug is strictly contraindicated for use in women due to the risk of fetal harm, regulatory labels do not document a specific drug interaction between Duagen and oral contraceptives.

Q: Is it normal to have mild headaches when starting Duagen?

A: Headaches have been reported in adverse event data or post-marketing surveillance, though they are not consistently listed among the most frequent side effects observed in the primary clinical trials.

Q: Can Duagen be used by people with diabetes?

A: Diabetes itself is not listed as an absolute contraindication. However, some clinical studies have noted that patients with poorly managed diabetes may be subject to careful monitoring.

Q: What does 'contraindication' mean in relation to Duagen?

A: A contraindication is a medical condition or factor that serves as a reason to withhold a certain medical treatment due to the high risk involved. For Duagen, official documentation lists examples such as a known allergy, severe liver impairment, and use by women or children.

Q: Are there any dietary restrictions I need to follow while using Duagen?

A: Regulatory documents suggest limiting or avoiding alcohol consumption. The medicine itself can be taken with or without food and does not have specific mandatory dietary restrictions.

How should Duagen be stored and disposed of?

How to Store and Dispose of Duagen (Dutasteride Soft Capsules)

Duagen must be stored at a Controlled Room Temperature of 25 C (77 F), with permitted excursions between 15 C and 30 C (59 F to 86 F). The medicine must be kept from freezing and stored away from direct light, excess heat, and moisture. Store the capsules in the tightly closed original container and keep them out of the sight and reach of children.

Handling and Disposal

Duagen capsules should not be handled by women who are pregnant or may become pregnant due to the risk of dermal absorption. If contact occurs with a leaking capsule, wash the area immediately with soap and water. Do not throw away unused or expired medicine via wastewater or household waste; consult a pharmacist for official disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Duagen  found in:

A-Z Index: